Citation Impact
Citing Papers
Phase III Study Comparing Cisplatin Plus Gemcitabine With Cisplatin Plus Pemetrexed in Chemotherapy-Naive Patients With Advanced-Stage Non–Small-Cell Lung Cancer
2008 Standout
Predictors of Postoperative Pain and Analgesic Consumption
2009 Standout
Prevalence and risk of violence against children with disabilities: a systematic review and meta-analysis of observational studies
2012 Standout
Transparent reporting of a multivariable prediction model for individual prognosis or diagnosis (TRIPOD): The TRIPOD statement
2015 Standout
EULAR recommendations for the use of imaging in large vessel vasculitis in clinical practice
2018 Standout
Phase III randomized trial comparing moderate-dose cisplatin to combined cisplatin and carboplatin in addition to mitomycin and ifosfamide in patients with stage IV non-small-cell lung cancer
2000
Reporting recommendations for tumor marker prognostic studies (REMARK): explanation and elaboration
2012
NRF2 and KEAP1 mutations: permanent activation of an adaptive response in cancer
2009 Standout
Transparent reporting of a multivariable prediction model for individual prognosis or diagnosis (TRIPOD): the TRIPOD statement
2015 Standout
The role of microvessel density on the survival of patients with lung cancer: a systematic review of the literature with meta-analysis
2002
QuPath: Open source software for digital pathology image analysis
2017 Standout
Granulocyte colony-stimulating factor promotes tumor angiogenesis via increasing circulating endothelial progenitor cells and Gr1+CD11b+ cells in cancer animal models
2005
Extracorporeal organ support (ECOS) in critical illness and acute kidney injury: from native to artificial organ crosstalk
2018
Primary Tumor Standardized Uptake Value (SUVmax) Measured on Fluorodeoxyglucose Positron Emission Tomography (FDG-PET) is of Prognostic Value for Survival in Non-small Cell Lung Cancer (NSCLC): A Systematic Review and Meta-Analysis (MA) by the European Lung Cancer Working Party for the IASLC Lung Cancer Staging Project
2008
Guidelines on the radical management of patients with lung cancer
2010
ERS/ESTS clinical guidelines on fitness for radical therapy in lung cancer patients (surgery and chemo-radiotherapy)
2009 Standout
Lung Cancer
2008 Standout
Classification and mutation prediction from non–small cell lung cancer histopathology images using deep learning
2018 Standout
Assessing risk of bias in prevalence studies: modification of an existing tool and evidence of interrater agreement
2012 Standout
Selective Reporting Biases in Cancer Prognostic Factor Studies
2005
Mechanisms of polymyxin resistance: acquired and intrinsic resistance in bacteria
2014 Standout
Influence of tumour micro-environment heterogeneity on therapeutic response
2013 StandoutNature
The role of RAS oncogene in survival of patients with lung cancer: a systematic review of the literature with meta-analysis
2004
Reporting Recommendations for Tumor Marker Prognostic Studies (REMARK): Explanation and Elaboration
2012
Current and future perspectives of liquid biopsies in genomics-driven oncology
2018 Standout
Molecular mechanisms of cisplatin resistance
2011 Standout
Selective Publication of Antidepressant Trials and Its Influence on Apparent Efficacy
2008 Standout
High expression of BCL-2 predicts favorable outcome in non-small cell lung cancer patients with non squamous histology
2010
Acute kidney injury
2019 Standout
Combination of topotecan and etoposide as a salvage treatment for patients with recurrent small cell lung cancer following irinotecan and platinum first-line chemotherapy
2007
Early and locally advanced non-small-cell lung cancer (NSCLC): ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
2017 Standout
The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration
2009 Standout
Development of a biosensor-based method for detection and isotyping of antibody responses to adenoviral-based gene therapy vectors
2002
Survival improvement in resectable non-small cell lung cancer with (neo)adjuvant chemotherapy: Results of a meta-analysis of the literature
2005
Promises and challenges for the implementation of computational medical imaging (radiomics) in oncology
2017 Standout
Surgical implications of the new IASLC/ATS/ERS adenocarcinoma classification
2011
Cytogenetic and molecular aspects of lung cancer
2005
The role of EGF-R expression on patient survival in lung cancer: a systematic review with meta-analysis
2002
Chemotherapy as treatment of primary and recurrent small cell lung cancer
2001
One mouse, one patient paradigm: New avatars of personalized cancer therapy
2013
An ultrasensitive method for quantitating circulating tumor DNA with broad patient coverage
2014 Standout
Colistin: an update on the antibiotic of the 21st century
2012
MicroRNA signatures in human cancers
2006 Standout
TP53 Mutations in Nonsmall Cell Lung Cancer
2011
Targeting DNA topoisomerase II in cancer chemotherapy
2009 Standout
Chronic kidney disease after acute kidney injury: a systematic review and meta-analysis
2011 Standout
Efficacy of gemcitabine plus platinum chemotherapy compared with other platinum containing regimens in advanced non-small-cell lung cancer: a meta-analysis of survival outcomes
2004
A typology of reviews: an analysis of 14 review types and associated methodologies
2009 Standout
Structure and function of “metalloantibiotics”
2003
The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration
2009 Standout
Erlotinib in Lung Cancer — Molecular and Clinical Predictors of Outcome
2005 Standout
Radiomics: Extracting more information from medical images using advanced feature analysis
2012 Standout
Radiomics: the bridge between medical imaging and personalized medicine
2017 Standout
Tumor Angiogenesis
2008 Standout
Strengthening the Reporting of Observational Studies in Epidemiology (STROBE): Explanation and Elaboration
2007 Standout
Tracking of childhood overweight into adulthood: a systematic review of the literature
2008 Standout
The PRISMA Statement for Reporting Systematic Reviews and Meta-Analyses of Studies That Evaluate Health Care Interventions: Explanation and Elaboration
2009 Standout
Strengthening the Reporting of Observational Studies in Epidemiology (STROBE)
2007 Standout
Small-cell lung cancer
2011
Biochemical Modulation of Cisplatin Mechanisms of Action: Enhancement of Antitumor Activity and Circumvention of Drug Resistance
2003 Standout
Molecular characterization of small peripheral lung tumors based on the analysis of fine needle aspirates.
2008
Transparent Reporting of a multivariable prediction model for Individual Prognosis Or Diagnosis (TRIPOD): Explanation and Elaboration
2015 Standout
Guidelines for Management of Incidental Pulmonary Nodules Detected on CT Images: From the Fleischner Society 2017
2017 Standout
A Simple Detection Method for Low-Affinity Membrane Protein Interactions by Baculoviral Display
2008 StandoutNobel
Strengthening the Reporting of Observational Studies in Epidemiology (STROBE): Explanation and Elaboration
2007 Standout
Prognostic and Predictive Importance of p53 and RAS for Adjuvant Chemotherapy in Non–Small-Cell Lung Cancer
2007
p53 and HER2/neu Expression in Relation to Chemotherapy Response in Patients with Non-Small Cell Lung Cancer
2006
Assessing Bias in Studies of Prognostic Factors
2013 Standout
Combination therapy in combating cancer
2017 Standout
Lung Adjuvant Cisplatin Evaluation: A Pooled Analysis by the LACE Collaborative Group
2008 Standout
Surface Plasmon Resonance Sensors for Detection of Chemical and Biological Species
2008 Standout
Advances in Copper Complexes as Anticancer Agents
2013 Standout
Evaluation of the Quality of Prognosis Studies in Systematic Reviews
2006
Transparent Reporting of a multivariable prediction model for Individual Prognosis Or Diagnosis (TRIPOD): The TRIPOD Statement
2015 Standout
Sedentary Time and Its Association With Risk for Disease Incidence, Mortality, and Hospitalization in Adults
2015 Standout
American Society of Clinical Oncology Treatment of Unresectable Non–Small-Cell Lung Cancer Guideline: Update 2003
2003 Standout
The Measurement of Observer Agreement for Categorical Data
1977 Standout
Systematic reviews: CRD's guidance for undertaking reviews in health care
2010 Standout
Works of F. Lemaı̂tre being referenced
Propofol, midazolam, vancomycin and cyclosporine therapeutic drug monitoring in extracorporeal membrane oxygenation circuits primed with whole human blood
2015
Role of p53 as a prognostic factor for survival in lung cancer: a systematic review of the literature with a meta-analysis
2001
A systematic review of the role of etoposide and cisplatin in the chemotherapy of small cell lung cancer with methodology assessment and meta-analysis
2000
Assay of Colistin and Colistin Methanesulfonate in Plasma and Urine by Liquid Chromatography-Tandem Mass Spectrometry
2010
Phase II and III studies with new drugs for non-small cell lung cancer: a systematic review of the literature with a methodology quality assessment.
2000
Haematological colony-stimulating factor (CSF) in the treatment of small-cell lung cancer (SCLC). A systematic review of the literature with meta-analysis
2001
The role of mitomycin in the treatment of non-small cell lung cancer: a systematic review with meta-analysis of the literature
2001